Acasti Pharma Inc.

ACST | NASDAQ | 1 Sledující

$3.37

4.01%

$0.13

Sledovat

Overview Metrics Financials

Company Quality

Profitability Score

9/100

Solvency Score

50/100

Dividends

Dividends data currently unavailable.

Earnings

8/7/2025

in 48 days

Revenue est.

EPS est.

My Notes

You haven't added any notes for this stock yet. Use this space to record your insights or strategies.

Profile

Healthcare

Sektor

Biotechnology

Průmysl

Mr. Prashant Kohli

CEO

Zaměstnanci

Laval

Centrála

Země

Key Metrics TTM

Valuation

Market cap.

$34M

Enterprise Value

$23M

Price to Earnings

-2.77

Price to Sales

0.00

Price to Book

0.74

Price to Cash Flow

-2.11

Profitability

Return on Assets

-22.83%

Return on Equity

-24.37%

Return on Invested Capital

-18.73%

Gross Margin

0.00%

Operating Margin

0.00%

Net Margin

0.00%

Liquidity

Quick Ratio

6.06

Current Ratio

6.06

Cash Ratio

5.61

Inventory Turnover

0.00

Asset Turnover

0.00

Total Liabilities

$12M

Solvency

Debt to Assets

0.00

Debt to Equity

N/A

Interest Coverage

-52.44

Equity Ratio

0.85

Long-term Debt to Cap.

0.00

Altman Z-Score

-3.32

Performance

Performance data currently unavailable.

Earnings Waterfall

Debt level and coverage

Debt level and coverage data currently unavailable.

Earnings

Feed

There are no posts to show right now.